Supernus Pharmaceuticals Share Holder Equity 2011-2024 | SUPN

Supernus Pharmaceuticals share holder equity from 2011 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Supernus Pharmaceuticals Annual Share Holder Equity
(Millions of US $)
2023 $922
2022 $886
2021 $816
2020 $745
2019 $595
2018 $453
2017 $267
2016 $192
2015 $88
2014 $41
2013 $33
2012 $58
2011 $9
2010 $0
Supernus Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $)
2024-03-31 $929
2023-12-31 $922
2023-09-30 $912
2023-06-30 $920
2023-03-31 $912
2022-12-31 $886
2022-09-30 $853
2022-06-30 $841
2022-03-31 $828
2021-12-31 $816
2021-09-30 $810
2021-06-30 $786
2021-03-31 $754
2020-12-31 $745
2020-09-30 $709
2020-06-30 $666
2020-03-31 $613
2019-12-31 $595
2019-09-30 $557
2019-06-30 $523
2019-03-31 $480
2018-12-31 $453
2018-09-30 $422
2018-06-30 $390
2018-03-31 $352
2017-12-31 $267
2017-09-30 $252
2017-06-30 $229
2017-03-31 $206
2016-12-31 $192
2016-09-30 $173
2016-06-30 $110
2016-03-31 $97
2015-12-31 $88
2015-09-30 $79
2015-06-30 $72
2015-03-31 $64
2014-12-31 $41
2014-09-30 $36
2014-06-30 $33
2014-03-31 $29
2013-12-31 $33
2013-09-30 $12
2013-06-30 $36
2013-03-31 $41
2012-12-31 $58
2012-09-30 $25
2012-06-30 $38
2012-03-31 $0
2011-12-31 $9
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.663B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.040B 6.57
Dr Reddy's Laboratories (RDY) India $13.038B 19.39
BridgeBio Pharma (BBIO) United States $4.901B 0.00
Bausch Health Cos (BHC) Canada $2.746B 2.12
Amphastar Pharmaceuticals (AMPH) United States $1.937B 11.65
Taysha Gene Therapies (TSHA) United States $0.400B 0.00
Personalis (PSNL) United States $0.200B 0.00
Assembly Biosciences (ASMB) United States $0.083B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00